4 results  1 of 1 

1 Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
Min Joo Kim, Young Joo Park
Int J Thyroidol.2018;11(2):61-70.   Published online 2018 November 30     DOI: http://dx.doi.org/10.11106/ijt.2018.11.2.61
      
2 Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel
Young-Min Son, Joo-Young Roh, Eun-Kyung Cho, Jong-Rok Lee
Ann Dermatol.2011;23(Suppl 3):S314-S318.   Published online 2011 December 27     DOI: http://dx.doi.org/10.5021/ad.2011.23.S3.S314
      
3 Stevens-Johnson Syndrome Induced by Vandetanib
Jimi Yoon, Chee Won Oh, Chi Yeon Kim
Ann Dermatol.2011;23(Suppl 3):S343-S345.   Published online 2011 December 27     DOI: http://dx.doi.org/10.5021/ad.2011.23.S3.S343
      
4 Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer
Jeeyun Ahn, Won Ryang Wee, Jin Hak Lee, Joon Young Hyon
Korean J Ophthalmol.2011;25(5):355-357.   Published online 2011 September 20     DOI: http://dx.doi.org/10.3341/kjo.2011.25.5.355
      

 1 of 1